Type 2 diabetes
flowchart AA["Associated Authors (1)"] C[Type 2 diabetes] BC["Broader Concepts (1)"] NC["Narrower Concepts (34)"] C== skos:broader ==>BC NC== skos:broader ==>C AA== dcterms:relation ==>C click BC "#broader-concepts" click NC "#narrower-concepts" click AA "#associated-authors" NI["add incoming edge"] NO["add outgoing edge"] NI-- ? -->C C-- ? -->NO click NI "#add-incoming-edge" click NO "#add-outgoing-edge" style NI stroke-width:2px,stroke-dasharray: 5 5 style NO stroke-width:2px,stroke-dasharray: 5 5
- Wikidata
- https://www.wikidata.org/wiki/Q3025883
- OpenAlex ID
- https://openalex.org/C2777180221 (API record)
- OpenAlex Description
- type of diabetes mellitus with high blood sugar and insulin resistance
- OpenAlex Level [?]
- 3
Broader Concepts
Narrower Concepts
- Basal insulin
- Canagliflozin
- Dapagliflozin
- Diabetes control
- Diabetes management
- Diabetes treatment
- Dipeptidyl peptidase-4
- Dipeptidyl peptidase-4 inhibitor
- Empagliflozin
- Exenatide
- Glimepiride
- Glucagon-like peptide-1
- Glycated haemoglobin
- Glycated hemoglobin
- Glycosylated haemoglobin
- Impaired glucose tolerance
- Incretin
- Insulin aspart
- Insulin glargine
- Insulin lispro
- Linagliptin
- Liraglutide
- Macrovascular disease
- Maturity onset diabetes of the young
- Nateglinide
- Oral hypoglycemic agents
- Pioglitazone
- Prediabetes
- Renal glucose reabsorption
- Repaglinide
- Sitagliptin
- Thiazolidinedione
- United Kingdom Prospective Diabetes Study
- Vildagliptin
Associated Authors
Add Incoming Edge
Login via ORCiD to contribute.
Add Outgoing Edge
Login via ORCiD to contribute.